Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management.

Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management. R I Med J (2013). 2022 Nov 01; 105(9):25-29.

View in: PubMed